Gpr75-deficient mice are protected from high-fat diet-induced obesity
These medications slow gastric emptyingthe rate at which food moves from the stomach into the small intestinewhich contributes to increased satiety and improved glycemic control
DiNicolantonio, J., Lavie, C., Fares, H., Menezes, A., & OKeefe, J
The selectivity matters
All testing was conducted during the animals light cycle
However, first-in-class drugs designed to activate these pathways, such as DPP8/9 inhibitors for pyroptosis, RIPK1 activators for necroptosis and GPX4 inhibitors for ferroptosis, have yet to enter clinical trials for AML, highlighting a translational gap and the need for further research (13,103,159)